CIK 0001455365
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
COGNITION THERAPEUTICS INC
Sign in to watch- Ticker
- CGTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 412-481-2210
- Business address
- 2500 WESTCHESTER AVE, PURCHASE, NY, 10577
- Former names
- COGNITION THERAPUTICS INC
- 4 Grant or award Director acquired 8,500 shares (grant or award)
- 4 Shares withheld for taxes Chief Financial Officer gave up 8,699 shares (to pay taxes)
- 4 Open-market buy CEO & President bought 5,700 shares at $1.75 ($9,975)
- 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 60,000 shares (grant or award)
- 4 Grant or award CEO & President acquired 75,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Medical Officer gave up 12,777 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & President gave up 27,828 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 500,095 shares (grant or award)
- 4 Grant or award Director acquired 500,095 shares (grant or award)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 109,824 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Medical Officer acquired 94,406 shares (grant or award)
Page 3 of 6 · 117 filings